Simon Mugo

Nairobi

Financial Content Strategist at Freelance

A financial writer who covers the UK and US stock markets, Foex and Crypto news at https://t.co/bL5o32un61.

Featured in: Favicon

eepower.com Favicon

leaprate.com Favicon

invesbrain.com Favicon

nxtmine.com Favicon

asktraders.com Favicon

thinkmarkets.com

Articles

Forex trading hours: Key sessions, time zones & strategies

Nov 12, 2024 | thinkmarkets.com | Simon Mugo

Forex trading hours: Key sessions, time zones & strategies
1N4148 Incorporating 741 IC Temperature Sensor

May 28, 2024 | hackster.io | Simon Mugo

Things used in this project ×11N4148 – General Purpose Fast Switching×1Multi-Turn Precision Potentiometer- 10k ohms (25 Turn)×1Creating a simple temperature sensor using a diode (1N4148) and an operational amplifier (741 IC) is straightforward.
TSL25911 Light Sensor

Apr 15, 2024 | hackster.io | Simon Mugo

Things used in this project ×1×1IntroductionWe interact with different intensities and strengths of light in our daily activities. Therefore, detecting the amount of ambient light we interact with is very important. There are several ways this light can be detected, and the simplest form of sensor to do such tasks is the Light-Dependent Resistor (LDR). Besides that, many other improved methods exist that can be deployed.
SIM800 GPS module

Apr 1, 2024 | hackster.io | Simon Mugo

Things used in this project ×1ElevatorThis project demonstrates how you can develop various GPS/ GPRS and SMS capability developments via the SIM800 integrated circuit. It introduces an electronic board that can connect with a microcontroller such as Atmega 328p, STM32, and ESP32, giving it the most required GPRS, GPS, and SMS data transmission and location tracking functionalities.
Vaccines in Development

Mar 28, 2024 | invesbrain.com | John Sterling |Simon Mugo |Tyler Durden

RNA-based immunizing agents have enriched the repertoire of technologies used for vaccine development. An analysis of the active clinical trials in early Phase I and Phase I during the year of 2023 illustrates this point. A total of 161 active vaccine trials were registered at clinicaltrials.gov. Information from these trials was used to plot ( Chart 1) and ( Chart 2) SARS-CoV-2/COVID-19 trials were excluded to give more evidence to other disease targets.
Study explores the future of at-home cancer treatment

Mar 28, 2024 | invesbrain.com | John Sterling |Simon Mugo |Tyler Durden

RNA-based immunizing agents have enriched the repertoire of technologies used for vaccine development. An analysis of the active clinical trials in early Phase I and Phase I during the year of 2023 illustrates this point. A total of 161 active vaccine trials were registered at clinicaltrials.gov. Information from these trials was used to plot ( Chart 1) and ( Chart 2) SARS-CoV-2/COVID-19 trials were excluded to give more evidence to other disease targets.
UnitedHealth Provides $3.3Bn in Loans to Healthcare Providers

Mar 28, 2024 | leaprate.com | Simon Mugo

In response to the urgent need for liquidity among care providers, UnitedHealth initiated a temporary support program earlier in the month. This initiative aims to alleviate the financial strain by offering loans, which providers are expected to repay within 45 business days.
Walgreens Incurs $5.8Bn Charge on VillageMD Amid Cost-Cutting

Mar 28, 2024 | leaprate.com | Simon Mugo

Under the leadership of CEO Rosalind Brewer, the company sought to enhance its healthcare offerings by investing heavily in VillageMD, a network of doctors’ clinics known for consuming substantial cash flows. Over recent years, Walgreens has poured more than $6 billion into acquiring a majority stake in VillageMD, further bolstering its healthcare footprint with a $3.5 billion investment in Summit Health in 2022.
Flutter Share Price Rose 5.76% on Upbeat Jeffries' Investor Note

Mar 28, 2024 | asktraders.com | Simon Mugo

The Flutter Entertainment PLC (LON: FLTR) share price rose 5.76% after an analyst at Jeffries issued an investor note about the company. Jefferies recently provided insights into the company’s market positioning amidst a flurry of regulatory uncertainties in the United States, spotlighting the company's resilience and strategic outlook. YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY.
AO World Shares Surged 12.8% on Its Pre-Close Trading Statement

Mar 28, 2024 | asktraders.com | Simon Mugo

The AO World PLC (LON: AO) share price surged 12.8% after the company issued a pre-close statement for its 2024 financial year ending 31 March 2024. The update offers insight into the company's financial health and projections, reinforcing its market position. YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY. For the fiscal year ending March 31, 2024, AO World projects its revenue to approximately £1.04 billion, underscoring its robust performance despite the volatile retail landscape.